search
Back to results

Effects of Vitamin D Supplementation on SOD,IL-6 and Insulin Resistance in Type 2 Diabetes Mellitus (DM) (DM)

Primary Purpose

Type2 Diabetes Mellitus

Status
Active
Phase
Not Applicable
Locations
Indonesia
Study Type
Interventional
Intervention
Vitamin D 5000 IU
Placebo
Sponsored by
Trisakti University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Type2 Diabetes Mellitus

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • male and female, aged > 18 years
  • period of DM ≤ 3 years
  • using a single anti-diabetic drug (monotherapy)
  • HbA1c > 6,5%

Exclusion Criteria:

  • receive insulin therapy
  • kidney disease, liver disease
  • pregnant and lactating women
  • allergy history
  • hypercalcemia history
  • consumption of vitamin D in the last 3 months

Sites / Locations

  • Community Health Centers Kecamatan Mampang Prapatan

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Intervention group

control group

Arm Description

Vitamin D, dosage form chewable tablet, dosage 5000 IU, frequency every day, duration six months

Placebo (microcrystalline,calcium carbonate, sodium starch), dosage form chewable tablet, frequency every day, duration six month

Outcomes

Primary Outcome Measures

level of Superoxide Dismutase (SOD)
SOD
Interleukin-6 (IL-6)
IL-6 in monocyte: % (method immunoflowcytometry);
pancreatic and duodenal homeobox 1(PDX-1) expression
PDX-1 expression : ct (method polymerase chain reaction /PCR);
Homeostatic Model Assessment for Insulin Resistance (HOMA-IR)
HOMA-IR : formula (fasting insulin (μIU/mL) x fasting blood glucose (mg/dL)/405

Secondary Outcome Measures

vitamin D level
Vitamin D: ng/mL;
(hemoglobin glycate) HbA1C
HbA1c: % ;
fasting blood glucose
Fasting blood glucose: mg/dL ;
fasting insulin
Fasting insulin: μIU/mL

Full Information

First Posted
October 17, 2022
Last Updated
April 10, 2023
Sponsor
Trisakti University
search

1. Study Identification

Unique Protocol Identification Number
NCT05596383
Brief Title
Effects of Vitamin D Supplementation on SOD,IL-6 and Insulin Resistance in Type 2 Diabetes Mellitus (DM)
Acronym
DM
Official Title
THE EFFECT OF VITAMIN D SUPPLEMENTATION ON IMPROVING PANCREAS BETA CELL FUNCTION IN TYPE 2 DIABETES MELLITUS: STUDY OF SOD,IL-6,PDX-1 EXPRESSION, and INSULIN RESISTANCE
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
February 12, 2022 (Actual)
Primary Completion Date
June 23, 2023 (Anticipated)
Study Completion Date
June 23, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Trisakti University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The aim of this intervention clinical study are: evaluation the effect of vitamin D supplementation on anti-oxidant status, inflammation, insulin resistance in patients type 2 diabetes mellitus. The research question is how the effect of vitamin D supplementation for 3 and 6 months on anti-oxidant status, inflammation and insulin resistance in patients type 2 diabetes mellitus. The main tasks participants will be asked to do: interviews, filling the questionnaires, and giving informed consent after receiving an explanation by the researcher about the purpose of the research taking blood for screening examination which includes examination of Serum Glutamic Pyruvic Transaminase (SGPT), albumin, creatinine and blood Ca. participant who meet the inclusion and exclusion criteria, performed a physical examination (height and weight) and blood collection for examination 25(OH)D. Subjects/participant with vitamin D deficiency and insufficiency will be included in randomization, two groups: the group that received vitamin D3 5,000 IU and the group that received a placebo. Vitamin D 5000 IU and placebo taken daily for 6 months. Observations for 3 months and 6 months from the first time supplementation was given. Treatments they'll be given: During the study, the subject's clinical condition will be monitored. Subject observations are monitored by telephone or google form to subject or their families
Detailed Description
Participant register: Patients type 2 DM aged > 18 years who went to the Community Health Centers Mampang were interviewed, filled out questionnaires, and gave informed consent.Interview by interviewers with at least high school education after being given training first by researchers. The data is entered in a computer excel table by the researcher. Accuracy, completeness of registration data using the screening form. Data that contains detailed descriptions of each variable used by the registry: Gender: differences in the nature, form, and biological function of men and women that determine differences in reproduction, by interview using a questionnaire and identity card. Duration DM: time from the first time being diagnosed DM until the start of the study, expressed in months Subject's age: calculated from the time the study began with the date of birth listed on the identity card. Standard Operating Procedures to address registry operations and analysis activities: patient recruitment : Patients type 2 DM aged > 18 years who went to the Community Health Centers Mampang were interviewed. data collection: using screening form data management : using table excel computer data analysis : using Statistical Package for the Social Sciences (SPSS) versi 23 report for adverse event: using form adverse event Sample size assessment : formula for hypothesis testing the mean difference of two groups Plan for missing data : back up data Statistical analysis plan to address the primary and secondary objectives: normality test (kolmogorov Smirnov), test statistic (T independent test or Mann Whitney test, Anova test)

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type2 Diabetes Mellitus

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The study was divided into two groups, the intervention group and the control group. The intervention group received vitamin D 5000 IU/day for 6 months and the control group received a placebo (contains microcrystalline, calcium carbonate, sodium starch) for 6 months
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
112 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention group
Arm Type
Experimental
Arm Description
Vitamin D, dosage form chewable tablet, dosage 5000 IU, frequency every day, duration six months
Arm Title
control group
Arm Type
Placebo Comparator
Arm Description
Placebo (microcrystalline,calcium carbonate, sodium starch), dosage form chewable tablet, frequency every day, duration six month
Intervention Type
Dietary Supplement
Intervention Name(s)
Vitamin D 5000 IU
Intervention Description
Intervention vitamin D 5000 IU per day, duration six months, dosage form chewable tablet
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
Placebo
Primary Outcome Measure Information:
Title
level of Superoxide Dismutase (SOD)
Description
SOD
Time Frame
Change from Baseline at 3 and 6 months
Title
Interleukin-6 (IL-6)
Description
IL-6 in monocyte: % (method immunoflowcytometry);
Time Frame
Change from Baseline at 3 and 6 months
Title
pancreatic and duodenal homeobox 1(PDX-1) expression
Description
PDX-1 expression : ct (method polymerase chain reaction /PCR);
Time Frame
Change from Baseline at 3 and 6 months
Title
Homeostatic Model Assessment for Insulin Resistance (HOMA-IR)
Description
HOMA-IR : formula (fasting insulin (μIU/mL) x fasting blood glucose (mg/dL)/405
Time Frame
Change from Baseline at 3 and 6 months
Secondary Outcome Measure Information:
Title
vitamin D level
Description
Vitamin D: ng/mL;
Time Frame
Change from Baseline at 3 and 6 months
Title
(hemoglobin glycate) HbA1C
Description
HbA1c: % ;
Time Frame
Change from Baseline at 3 and 6 months
Title
fasting blood glucose
Description
Fasting blood glucose: mg/dL ;
Time Frame
Change from Baseline at 3 and 6 months
Title
fasting insulin
Description
Fasting insulin: μIU/mL
Time Frame
Change from Baseline at 3 and 6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: male and female, aged > 18 years period of DM ≤ 3 years using a single anti-diabetic drug (monotherapy) HbA1c > 6,5% Exclusion Criteria: receive insulin therapy kidney disease, liver disease pregnant and lactating women allergy history hypercalcemia history consumption of vitamin D in the last 3 months
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alvina Alvina
Organizational Affiliation
Universitas Trisakti
Official's Role
Principal Investigator
Facility Information:
Facility Name
Community Health Centers Kecamatan Mampang Prapatan
City
Jakarta
State/Province
DKI Jakarta
ZIP/Postal Code
12720
Country
Indonesia

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
29883970
Citation
Mansournia MA, Ostadmohammadi V, Doosti-Irani A, Ghayour-Mobarhan M, Ferns G, Akbari H, Ghaderi A, Talari HR, Asemi Z. The Effects of Vitamin D Supplementation on Biomarkers of Inflammation and Oxidative Stress in Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Horm Metab Res. 2018 Jun;50(6):429-440. doi: 10.1055/a-0630-1303. Epub 2018 Jun 8.
Results Reference
result
PubMed Identifier
29945132
Citation
Yu Y, Tian L, Xiao Y, Huang G, Zhang M. Effect of Vitamin D Supplementation on Some Inflammatory Biomarkers in Type 2 Diabetes Mellitus Subjects: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Ann Nutr Metab. 2018;73(1):62-73. doi: 10.1159/000490358. Epub 2018 Jun 26.
Results Reference
result
PubMed Identifier
25745497
Citation
Al-Sofiani ME, Jammah A, Racz M, Khawaja RA, Hasanato R, El-Fawal HA, Mousa SA, Mason DL. Effect of Vitamin D Supplementation on Glucose Control and Inflammatory Response in Type II Diabetes: A Double Blind, Randomized Clinical Trial. Int J Endocrinol Metab. 2015 Jan 10;13(1):e22604. doi: 10.5812/ijem.22604. eCollection 2015 Jan.
Results Reference
result

Learn more about this trial

Effects of Vitamin D Supplementation on SOD,IL-6 and Insulin Resistance in Type 2 Diabetes Mellitus (DM)

We'll reach out to this number within 24 hrs